Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism

Patient

Volumn 6, Issue 3, 2013, Pages 213-224

  Laliberte, Francois ^a   Bookhart, Brahim K ^b   Nelson, Winnie W ^b   Lefebvre, Patrick ^a   Schein, Jeff R ^b   Rondeau Leclaire, Jonathan ^a   Duh, Mei Sheng ^c  

^a GROUPE D ANALYSE   (Canada)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^c ANALYSIS GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; DIABETES MELLITUS; DOSAGE SCHEDULE COMPARISON; FEMALE; HEALTH INSURANCE; HUMAN; HYPERTENSION; LONG TERM CARE; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; ONCE DAILY DOSING FREQUENCY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT PLANNING; TWICE DAILY DOSING FREQUENCY; VENOUS THROMBOEMBOLISM; CHRONIC DISEASE; DRUG ADMINISTRATION; INSURANCE; LONGITUDINAL STUDY; MEDICATION COMPLIANCE; PSYCHOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; PSYCHOLOGICAL ASPECT; STATISTICS;

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSURANCE CLAIM REVIEW; INSURANCE, PHYSICIAN SERVICES; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 84891529294     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-013-0020-5     Document Type: Article

References (40)

1. Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728-40.
2. Schulman S, Crowther MA. How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood. 2012;119:3016-23.
3. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39:632-6.
4. Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica. 2002;87:1081-6.
5. Heit JA, Cohen AT, Anderson FA Jr, et al. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the U.S [poster presented at: 47th annual meeting of the American Society of Hematology (ASH); December 10-14, 2005, Atlanta]. Blood. 2005;106:267a.
6. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82:203-5.
7. Kopcke D, Harryman O, Benbow EW, et al. Mortality from pulmonary embolism is decreasing in hospital patients. J R Soc Med. 2011;104:327-31.
8. Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis. 2006;21:23-9.
9. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107:I22-30.
10. Coleman CI, Roberts MS, Sobieraj DM, et al. Effect of dosing frequency on chronic cardiovascular disease medication adherence. Curr Med Res Opin. 2012;28:1-12.
11. Coleman CI, Limone B, Sobieraj DM, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 2012;18:527-39.
12. Ganz DA, Glynn RJ, Mogun H, et al. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000;15:776-81.
13. Deitelzweig SB, Lin J, Kreilick C, et al. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes. Adv Ther. 2010;27:623-33.
14. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation. 2003;108:2726-9.
15. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86:452-63.
16. Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation. 2004;110:13-9.
17. Agnelli G. Prevention of venous thromboembolism in surgical patients. Circulation. 2004;110:4-12.
18. Lefebvre P, Laliberté F, Nutescu EA, et al. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries. J Manag Care Pharm. 2012;18:363-74.
19. IMS Health. IMS RxBenchmark: PharMetrics Integrated Database. http://www.imshealth.com/portal/site/ims/menuitem.d248e29c865 89c9c30e81c033208c22a/?vgnextoid=d6952a2e23264310VgnVC M100000ed152ca2RCRD& vgnextchannel=c03c90916e442310V gnVCM100000ed152ca2RCRD (Accessed 30 May 2013).
20. Sikka R, et al. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11:449-57.
21. Ho PM, et al. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;2009(119):3028-35.
22. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011;171:814-22.
23. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
24. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism: a prospective cohort study in 1,626 patients. Haematologica. 2007;92:199-205.
25. Goldhaber SZ, Buonameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835-46.
26. Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000;160:769-74.
27. Ostenberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
28. Iskedjian M, Addis A, Einarson T. Estimating the cost of hospital admissions due to patient nonadherence in Ontario, Canada. Pharmacoepidemiol Drug Saf. 1998;7:S92.
29. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990;263: 1653-7.
30. Iskedjian M, Einarson TR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002;24:302-16.
31. Haynes RB, Taylor DW, Snow JC, et al. Appendix I: annotated and indexed bibliography on compliance with therapeutic and preventative regimens. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: The Johns Hopkins University Press; 1979. p. 337-43.
32. Bae JP, Dobesh PP, Klepser DG, et al. Adherence and dosing frequency of common medications for cardiovascular patients. Am J Manag Care. 2012;18:139-46.
33. Toy EL, Beaulieu NU, McHale JM, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011;105:435-41.
34. Laliberté F, Nelson WW, Lefebvre P, et al. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Adv Ther. 2012;29: 675-90.
35. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15:e22-33.
36. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-310.
37. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6:592-9.
38. Blackwell B. The drug regimen and treatment compliance. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: The Johns Hopkins University Press; 1979. p. 144-56.
39. Haynes RB. Determinants of compliance: the disease of the mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: The Johns Hopkins University Press; 1979. p. 49-63.
40. Reid J. Medication compliance in the elderly: a review. J Clin Exp Gerontol. 1985;7:31-49.